|Bid||4.0100 x 1000|
|Ask||4.2200 x 900|
|Day's range||4.0600 - 4.4400|
|52-week range||4.0600 - 106.0000|
|Beta (5Y monthly)||2.26|
|PE ratio (TTM)||N/A|
|Earnings date||21 Jun 2023 - 26 Jun 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||2.75|
Key Insights The considerable ownership by individual investors in RedHill Biopharma indicates that they collectively...
Market forces rained on the parade of RedHill Biopharma Ltd. ( NASDAQ:RDHL ) shareholders today, when the covering...
RedHill Biopharma ( NASDAQ:RDHL ) Second Quarter 2022 Results Key Financial Results Revenue: US$18.3m (down 15% from 2Q...